#astrocytoma treatment
Explore tagged Tumblr posts
Text
Virtual Consultations with Brain Surgeons Near Me: What to Expect
In recent years, the healthcare landscape has undergone a significant transformation, particularly in the realm of specialized medical services. One area that has seen considerable advancements is neurosurgery, where the emergence of virtual consultations has made it easier for patients to access expert care without the need for physical appointments. This article delves into what patients can expect when seeking virtual consultations with brain surgeons near them, ensuring they are well-informed and prepared for this innovative approach to healthcare.

The Rise of Virtual Consultations in Neurosurgery
The shift towards virtual consultations represents a broader trend within the medical field, where technology is leveraged to enhance patient experience and improve accessibility. Patients no longer need to travel long distances to meet with leading experts in neurosurgery; instead, they can connect with brain surgeons from the comfort of their homes. This approach not only saves time but also reduces the stress often associated with hospital visits.
Moreover, virtual consultations can be particularly beneficial for individuals with mobility issues or those living in remote areas. For many patients, finding a brain surgeon near me can be a daunting task, especially if there are limited options available locally. Virtual consultations break down these geographical barriers, allowing patients to consult with top-tier specialists regardless of their location.
Preparing for Your Virtual Consultation
When preparing for a virtual consultation with a brain surgeon, there are several key steps that patients should take to ensure a productive experience. Firstly, it is essential to gather all pertinent medical records and imaging studies, such as MRIs or CT scans. Having this information readily available will enable the surgeon to make a more accurate assessment of the patient's condition and provide tailored recommendations.
Additionally, patients should prepare a list of questions or concerns they wish to address during the consultation. This proactive approach not only helps in maximizing the time spent with the surgeon but also ensures that all important topics are covered. Patients should also check their technology setup prior to the consultation, ensuring that their internet connection is stable and that they have access to a device equipped with a camera and microphone.
What to Expect During the Consultation
Virtual consultations typically begin with an introduction, where the brain surgeon will discuss the patient's medical history and the purpose of the meeting. The surgeon may ask a series of questions to gain a comprehensive understanding of the patient's symptoms and previous treatments. Following this, the surgeon will review any uploaded medical records and imaging studies, providing insights based on the latest medical knowledge and their expertise.
Throughout the consultation, patients can expect a collaborative discussion regarding potential treatment options. The brain surgeon may outline various approaches, including both surgical and non-surgical options, and help the patient weigh the benefits and risks associated with each. This dialogue is crucial, as it empowers patients to make informed decisions about their health in partnership with their healthcare provider.
The Benefits of Virtual Consultations
One of the most significant advantages of virtual consultations is the increased accessibility to specialized care. Patients who may have previously felt overwhelmed by the prospect of traveling to a distant hospital can now receive expert opinions from the convenience of their homes. This increased accessibility can lead to earlier diagnosis and intervention, which is particularly important in the field of neurosurgery where timely treatment can make a substantial difference in outcomes.
Virtual consultations also offer flexibility. Patients can schedule appointments at times that suit their lives, reducing the need to take time off work or arrange for childcare. Furthermore, the ability to consult with multiple specialists virtually enables patients to gather diverse opinions before making critical medical decisions. This aspect is particularly valuable when navigating complex conditions that may require a multidisciplinary approach.
Follow-up Care and Ongoing Support
After the initial virtual consultation, patients can expect a clear plan for follow-up care. Depending on the condition, the brain surgeon may recommend additional tests, referrals to other specialists, or a follow-up consultation to monitor progress. Many surgeons also provide ongoing support through secure messaging platforms, allowing patients to ask questions and seek guidance as they navigate their treatment journey.
It’s important for patients to remain engaged with their healthcare team during this time. Keeping an open line of communication ensures that any emerging concerns can be addressed promptly. Additionally, patients should be proactive in adhering to the treatment plan discussed during the consultation, whether it involves medication management, lifestyle changes, or further diagnostic testing.
Conclusion
As the demand for specialized medical care continues to grow, the advent of virtual consultations with brain surgeons represents a significant leap forward in patient accessibility and convenience. This innovative approach not only allows for expert advice from the comfort of home but also fosters a collaborative relationship between patients and their healthcare providers.
For those seeking a trusted partner in their neurosurgical journey, Robert Louis MD offers comprehensive virtual consultations that cater to individual needs and circumstances. By prioritizing patient engagement and personalized care, Robert Louis MD stands out as a leader in the field, ensuring that patients receive the expert guidance they deserve. Whether you are exploring treatment options or seeking a second opinion, reaching out to Robert Louis MD can be the first step towards a healthier future.
0 notes
Text

“An 11-year-old girl who was misdiagnosed with sickness bugs and migraines was assessed by doctors about 30 times before they found that she had a brain tumour, according to her mother.
Tia Gordon, from Northampton, was admitted to hospital as an emergency despite previous visits to GPs, A&E and calls to 111.
Imogen Darby, Tia’s mother, said her daughter’s glasses prescription had also been changed four times before the tumour was found.
Darby had sought help regarding Tia’s migraines and vomiting for more than three years, before being told that the wait for an MRI scan would be at least eight months. It was only when Tia’s balance and ability to walk were affected that she was given an emergency scan, which found a brain tumour measuring about 3.5cm.”
Darby said: “I was told Tia had stomach bugs and migraines. The first thing I was told, because it was the summer, [was that] she just needed to drink more water.
“After probably a year, she got diagnosed with migraines and they gave her paracetamol for that. She was also given another medication for that and her final diagnosis in January from paediatrics was migraine with sickness.
“Over more than three years, I took Tia to doctors, she was refused MRIs, she was refused to be seen by emergency paediatrics, I called 111, I went to A&E. She had her glasses changed four times, she was given medication and she had a consultant, but it took for her to be unable to walk for her to get the care she needed.”
Darby first noticed Tia’s symptoms in March 2020 when she started vomiting with increasing frequency. Darby twice tried to get her daughter referred to emergency paediatrics, but was declined both times and told it was not an emergency.
Later, Tia began holding her neck in an unusual way and complained about stiffness, for which she was referred to a physiotherapist.
Despite several visits to A&E and calls to GPs and the NHS’s 111 service, Tia’s remained undiagnosed. From November 2023 to January 2024, Tia was vomiting violently every day, and began to lose her balance. “She was tipping her milk out in the kitchen sink,” Darby said. “She was standing there and … she didn’t notice she was doing it at all.”
After a phone call from Tia’s school, which said Tia was holding her neck and was off balance, Darby took her to Northampton General Hospital. While there, Tia was unable to walk in a straight line, and a CT scan revealed a pilocytic astrocytoma — the most common type of brain tumour in children.
Tia was taken to Queen’s Medical Centre in Nottingham, where she had a ten-hour operation to remove the tumour. “It was quite a horrendous day,” Darby said. “They managed to get 96 per cent of it out.”
Tia called the growth her “astronaut tumour”. Since the procedure, she gets very tired and can sometimes lose her balance. Her recovery will consist of an MRI scan every three months for the next five years, and she is having regular physiotherapy and meetings with neurologists.
She is keen to get back to her hobbies. Darby calls her “Dr Doolittle” due to her love for animals, and added that Tia is a keen reader and enjoys playing dodgeball.
Cameron Miller, director of external affairs and strategy at the Brain Tumour Charity, said “We wish Tia all the best with her continuing treatment and thank Imogen for sharing her story.
“Sadly, it’s one that we often hear. For many brain tumour patients, it simply takes too long to be diagnosed — and this is one of the reasons why we’re calling for a National Brain Tumour Strategy.”
93 notes
·
View notes
Text
What are the reasons and symptoms of Glioma brain cancer? The changes in the brain's DNA can cause Glioma cancer. There are various types of brain cancer glioma, such as Brainstem Glioma, Mixed Glioma, Ependymoma, Oligodendroglioma, Optic Glioma, and Astrocytoma. The symptoms of Glioma brain cancer are dizziness, numbness, speech problems, headache, seizure, personality change, and others. Glioma brain cancer survival rate depends on the grade level, and Grade 1 glioma cancer has a 95% success rate. Starting the treatment as soon as possible is necessary to get the best results.
4 notes
·
View notes
Text
Astrocytic Tumors Brain tumor is one of the most lethal forms of cancers with more than 13,000 deaths every year in the United States. Though we are still a long way from developing medical interventions that promise total recovery, advancements in the diagnostic methods such as MRS, ultrasonic aspiration and in surgical procedures such as intraoperative neuronavigation, Gamma Knife radiosurgery, etc., have improved the precision for the surgeon and outcome for the patient to a significant extent. It is hoped that our increasing understanding of the molecular pathology of the disease propelled by the huge amount of research devoted to the field would lead to developing a successful treatment plan for astrocytoma and all other forms of brain tumors in the near future. Introduction Brain tumor is one of the dangerous forms of cancer and in the United States alone more than 200,000 people are affected by it every year. Of these, primary brain tumors account for around 40,000 cases. Statistics indicate that approximately 13,000 people die of brain tumor every year making up 2% of all cancer related deaths in the U.S. Tumors are classified as primary or secondary based on the location of their origin. Cancers that originate within the brain cells are called primary tumors and those that are derived from other parts of the body into the brain are called metastatic or secondary brain tumors. Glial cells are the cells that nourish, insulate and support the neurons. They also form part of the blood brain barrier. Tumors derived from the glial cells account for 44.4% of all primary forms of brain tumor. Astrocytoma or tumors derived from the astrocyte cells account for 11.3% of all primary brain and CNS tumors and 21.6% of all gliomas. Let us have a brief overview of Astrocytoma, the condition, it's pathogenesis, diagnosis and treatment methods. The Glial Cells The brain is made up of two important cell types namely the neurons and the glial cells. While the neurons have action potential and constitute the main functional mechanism for the brain the glial cells are by no means less important. In fact the glial cells exceed neurons in number by 10 to 50 times. There are different types of glial cells namely astrocytes, oligodendrocytes and ependymal cells. The astrocytes are star shaped cells, which nourish, insulate and support the neurons. Astrocytes also perform cleanup operations by digesting dead neuron cells. Glioma is a collective term that refers to tumors that originate from these glial cells. Astrocytomas, Ependymomas, Oligodendrogliomas are the different types of gliomas derived from the corresponding cell types. Tumor Grades Besides the basic classification of malignant and benign forms, tumors are also classified based on the rate of development and appearance. The WHO classifies grade 1 tumor as normal under the microscope and with a very slow growth rate. These tumors can be effectively managed by surgery. Grade 2 tumors have a slightly faster growth rate and cellular abnormalities are clearly visible under microscopic observation. These tumors can affect neighboring cells and carry the risk of developing into higher-grade tumors. Grade 3 tumors are classified as malignant tumors, which grow rapidly and affect neighboring tissues at a fast rate. Grade 4 tumors are the most deadly in terms of their growth. They spread very fast and affect a large area. They are called necrotic tumors as they have dead cells in the center and they grow new blood vessels to sustain their rapid proliferation. Astrocytomas are classified into four types based on the above-mentioned grading. Pilocytic Astrocytomas are first grade astrocytomas that predominantly affect pediatric patients. Astrocytes are found along with rosenthal fibers and eosinophilic granular bodies. The lesions that appear in the brain tissue are referred to as "juvenile pilocytic astrocytoma." This condition accounts for 85% of cerebellar tumor. The preferred sites for this tumor include the cerebellum, cerebral hemispheres, ganglia, thalamus and the optic nerve. Fibrillary Astrocytoma is a grade-2 astrocytoma and it is not circumscribed. It is well differentiated and affects adjoining cells and is a tumor of the fibrillary or gemistocytic neoplastic astrocytes. In around 60% of the Patients diagnosed with this condition P53 mutations have been observed. It is found that this type of astrocytoma is common among patients who have Li-Fraumeni syndrome. (patients with inherited P53 mutation) Anaplastic Astrocytomas is a grade 3 astrocytoma and is a malignant form. This type shows increased cellularity and distinct nuclear atypia. This tumor is characterized by high TP53 mutations. Typically in this tumor, most of the genes that are concerned with cell progression are altered. The Glioblastoma Multiforme, a grade 4 and most malignant form of astrocytoma is anaplastic and composed of pleomorphic astrocytic tumor cells showing intense mitotic activity. Glioblastoma is the most common form of brain tumor accounting for 12% to 15% of all tumors and around 60% of all astrocytic tumors. There are two types of Glioblastoma as Dr. Vinay says, "One type begins as a low- or intermediate-grade astrocytoma and changes into a glioblastoma," the other type, known as the denovo form, seems to start out as a glioblastoma. This seems to be due to the differences in the genetic changes that trigger the growth of these tumors." it predominantly affects the cerebral hemispheres and has a high incidence rate for people between 45 and 70 years of age. The GBM is also one of the most complex forms of tumor where a single gene cannot be implicated as the precursor. To quote Dr. Vinay again, "there does not appear to be a single genetic basis that could explain the disease that we have been able to find. While genetics seems to play a role, it doesn't seem to be a 'one-hit' problem, like certain leukemias that can be traced to one gene; it's more like multiple hits that take place over a period of time." Amplification of the EGFR (epidermal growth factor receptor) is found in approximately 40% of primary gliblastoma cases. Mutations of the PTEN gene are also observed in 45% of primary gliblastomas. Pathogenesis There is no clearly identified molecular pathology for astrocytoma. Research is still focused on understanding the molecular pathologies underlying astrocytoma. However, research has indicated the following genetically derived pathologies. The following genes: PTEN/MMAC1, DMBT1 (deleted in malignant brain tumor-1), EGFR, TP53, P16, PDGFR, and retinoblastoma cell-cycle regulatory gene have all been indicated in the onset of astrocytoma. Though, today, alterations in these genes are well-known, the cause for these abnormal gene alterations remain unknown. The most commonly identified causes are the deletion of tumor suppressing genes such as p53, retinoblastoma, p16 as well as the addition of tumor promoting genes such as PDGFR, and EGFR. Mutation to the P53 tumor suppressor gene is an important factor in tumor development. Studies have shown that the P53 mutations are the most common among humans and hence carry a risk potential for developing cancers. Since the P53 gene is responsible for cell cycle regulation, which includes induction of apoptosis, aberration in the gene results in uncontrolled cell growth. Studies have also implicated RNA binding proteins in the pathogenesis of astrocytoma. The link between over expression of tyrosine kinase (which is a chief regulator found in malignant astrocytes) and the RNA posttranscriptional modifications are being closely studied. in Glioblastma multiforme (GBM), the most lethal form or grade 4 astrocytoma, researchers have observed aberrations on chromosome 10 resulting in the loss of tumor suppressing genes such as PTEN/MMAC1 along with other similar genes that regulate P. I3 Kinase and PKB/Akt pathways. Animal Studies have also attested that the P. I3 kinase (phosphoinositide-3-kinase) in particular has a vital role in defining and regulating the number and size of the cells in tissues. Further, molecular studies have also revealed the overexpression of tumor promoting genes such as EGFR and other Growth factor receptors that activate P21 - RAS signalling pathways. Also deletion of PTEN and a resultant increase in phosphorylated PKB/Akt has been shown to result in an increase in cell size. Hence downregulation of PI3 Kinase, PTEN, overexpression of EGFR and PFGFR, are some of the possible molecular pathologies. Symptoms and Diagnosis There are many different symtoms associated with astrocytoma or any type of brain tumor in general. Because there is an increase in intra-cranial pressure due to the increased cell mass, headache is a commonly observed symptom. Nausea, vomitting, dementia, changes in personality and mood swings are also observed. However, symptoms are mostly associated with the position of the tumor within the brain. For example, tumor in the occipictal lobe would result in visual hallucinations and impairment while a tumor positioned in the parietal lobe will lead to impaired motor functions. Diagnosis of astrocytoma involves a complete examination by the physician followed by a series of tests such as MRI, CT scan, angiogram and biopsy. The MRI uses a magnet, radio waves and computer to create high quality 3d images of the brain. The MRI is considered the best choice as it has a 81% to 100% specificity as compared to the CT scan which has 72% to 100% specificity. Using MRS chemical composition of the tumor and the metabolite intensities can also be ascertained along with the morphological characterisitcs. Thus MRI provides better information which is useful in grading the tumor. For grade 4 astrocytoma's spectroscopic studies reveal high Cho, high lipid, high lactate and low NAA values. However, the MRI testing is time consuming (40 to 90 minutes) and is problematic for claustrophobic patients. Biopsy of the affected brain tissue will also help in determining the nature of the abnormal tissue growth. Treatment Treatment for astrocytoma includes, surgery, chemotherapy, radiation and gluco corticoid medication. Treatment improves the survival rates for patients and the type of treatment depends on the growth and location of the tumor. First grade tumors such as Pilocytic Astrocytomas are easily treated by resection. In most cases removal of the affected part would be sufficient. However, if the location of the tumor makes surgery an impossible choice then the condition is treated by chemotherapy and radiotherapy. In fibrillary, anaplastic astrocytoma and Glioblastoma complete removal by surgery is followed by chemotherapy and radiation. Total cure is possible for Pilocytic Astrocytomas after surgery while the prognosis for fibrillary astrocytoma depends on whether or not the tumor cells are transformed into more malignant types. Also recurrence is high in fibrillary astrocytoma. With the advancements in medical technology such as intraoperative neuronavigation that allows the surgeon to see the surgical region on the computer screen, and the use of high power microscopes to magnify the surgical zone, it is possible to limit damage to adjacent healthy tissues while doing a tumor resection. Radiation therapy may be both external and internal. In the later case, radioactive materials are implanted near the tumor zones. It is now common to use biodegradable BCNU polymer wafer implants for radiation therapy. Also, the use of scalpel for tissue extraction can be eliminated by using the 'ultrasonic aspiration' method. Ultrasonic waves are focused on the tumor area to break it down and the fragments are removed by suction. Radiosurgery Stereotactic radiosurgery is a non-invasive form of therapy, which can be done in a session by a neurosurgeon. The aim of the therapy is to destroy the tumor cells by concentrating a series of cobalt 60 beams from different angles onto a spot. Since individual beams are not strong enough to destroy healthy cells the therapy does not affect healthy cells that is passes thorough but only affects the area on the brain where all the beams converge (the tumor zone). However, this therapy has its limitations and only an area of 4 cm can be treated at any one time so it might involve multiple sessions. Radiosurgery is typically recommended for patients who do not have the need for surgical intervention. However, this therapy is also used post surgery to remove traces of tumor cells that might still exist. Though the radiation does not destroy healthy cells, multiple sessions of radiotherapy are not recommended for children in view of the possible long-term damage to a brain which is still in the developmental stage. Chemotherapy Chemotherapy is a much older form of treatment and involves a combination of drugs to destroy the cancerous cells. The usefulness of drugs in the treatment of tumors is largely affected by the 'blood brain barrier' that filters of most toxic substances from entering the brain. Chemotherapy is usually given as a secondary therapy after surgery and alongside radiotherapy. Chemotherapy requires that the patient be healthy enough for the treatment. Drugs can be given orally or intravenously. Glucocorticoids are one of the main pharmacological interventions in providing symptomatic relief for patients affected by brain tumor. The edema that results from brain tumor increases the intra-cranial pressure and gives severe forms of headache. Glococorticoids and other cortisone drugs help in alleviating the symptoms by reducing the water level in the 'peritumoral zone' of the edema. Conclusion Glial tumors are the most common and dangerous forms of brain tumors. Treatment by a combination of methods may improve the prognosis and the quality of life for the patient. While in some tumors such as the Pilocytic Astrocytomas and Fibrillary Astrocytomas, total recovery maybe possible we are still a long way from providing complete relief for all the different types of astrocytomas. Treatments for astrocytoma may also result in serious side effects as it involves the brain. Advancements in the diagnostic methods such as MRS, ultrasonic aspiration and in surgical procedures such as intraoperative neuronavigation, Gamma Knife radiosurgery, etc. have improved the precision for the surgeon and outcome for the patient to a significant extent. However, significant advancements in molecular biology could only yield us the victory over the battle with tumor. It is hoped that with the huge volume of research that is currently underway in understanding the pathology of the disease it would not be long before successful treatment and prevention methods could be developed for astrocytoma and all other forms of brain tumors. Bibliography Capodano AM. Nervous system: Astrocytic tumors. Atlas Genet Cytogenet Oncol Haematol. November 2000. Available at, http://AtlasGeneticsOncology.org/Tumors/AstrocytID5007.html BTS, "Brain Tumor Facts & Statistics," Accessed Nov 18th 2007, available at http://www.tbts.org/itemDetail.asp?categoryID=384&itemID=16535 Karen T. Barker and Richard S. Houlston, "Overgrowth syndromes: Is dysfunctional P. 13 Kinase signalling a Unifying mechanism," European Journal of Human Genetics (2003) 11, 665-670. Available online at, http://www.nature.com/ejhg/journal/v11/n9/full/5201026a.html Medscape, " a Review of Astrocytoma Models: Molecular pathologies of Astrocytoma," Neurosurgical Focus 8(4), 2000 eMedicine, "Astrocytoma, Brain," Accessed on Noiv 18th 2007, available at http://www.emedicine.com/radio/topic60.htm Nobuaki Ishii and N. de Tribolet, "Are p53 mutations and p53 over expression prognostic factors for astrocytic tumors? Critical reviews in Neurosurgery, vol 8 / no 5, Sept 1998. Pamela a. Silver PhD, "RNA Binding Proteins in the Progression of Adult Astrocytic Tumors," Accessed Nov 18th 2007, Available online at, http://www.goldhirshfoundation.org/project_summaries_2002.htm NCI, "Adult Brain Tumors: Classification," Accesed Nov 18th 2007, available at http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/285.cdr#Section_285 Sosuke Minamikawa et.al,' Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging ', Neuroradiology, Vol 46, No 10, Oct 2004 CancerWise, "Glioblastoma Brain Tumors Puzzle Doctors: Studies Continue on How to Treat Formidable Disease," Accessed 19th Nov 2007, Available at, http://www.cancerwise.org/december_2002/display.cfm?id=dbb59002-1a31-48c6-b6823d1c45bff4b8&method=displayfull&color=green IRSA, "Astrocytomas," Accessed Nov 18th 2007, available at http://www.irsa.org/astrocytoma.html ISCID, "The Glial Cell," Accessed Nov 18th 2007, available at http://www.iscid.org/encyclopedia/The_Glial_Cell Read the full article
0 notes
Text
Spinal Cord Tumor Surgery in India
Introduction
Spinal cord tumors are abnormal growths that develop within or near the spinal cord, causing pain, neurological deficits, and mobility issues. Spinal Cord Tumor Surgery in India offers advanced medical care, skilled neurosurgeons, and cost-effective treatment options for patients seeking relief and recovery.
What is Spinal Cord Tumor Surgery in India?
Spinal cord tumor surgery is a procedure performed to remove benign or malignant tumors affecting the spinal cord, nerve roots, or surrounding structures. It is essential for preventing further neurological damage and improving the patient’s quality of life.
Types of Spinal Cord Tumors
Intramedullary Tumors – Tumors that grow inside the spinal cord (e.g., astrocytomas, ependymomas).2. Extramedullary Tumors – Tumors that develop outside the spinal cord but within the spinal canal (e.g., meningiomas, schwannomas).3. Metastatic Tumors – Cancerous tumors that spread to the spine from other parts of the body.
Who Needs Spinal Cord Tumor Surgery in India?
Patients who experience the following symptoms may require surgery:
Constant back or neck pain
Weakness or numbness in organs
Coordination or balance loss
bladder or bowel relaxation
Paralysis in severe cases
Procedure for Spinal Cord Tumor Surgery in India
Preoperative diagnosis: MRI, CT scan, and biopsy to determine the location and type of tumor.
Anesthesia: General anesthesia is administered to a painless process.
Surgical removal: Neurosurgeons remove the tumor using minimal invasive or open surgical techniques.
Spinal stabilization: If necessary, spinal fusion or implant is used to restore stability.
Postoperative Care: Intensive monitoring, physiotherapy, and rehabilitation for recovery.
📅 Book an Appointment Today! 📞 Contact us at +91 9468115100
0 notes
Text
0 notes
Text
Dr. Navneet Agrawal: Leading Spine Tumor Surgeon in Jaipur
When it comes to spine health, finding a trusted expert is crucial. In Jaipur, Dr. Navneet Agrawal has emerged as one of the most renowned spine tumor surgeons. With his extensive experience, state-of-the-art techniques, and compassionate care, Dr. Agrawal has become a beacon of hope for patients dealing with complex spinal conditions.
Expertise in Spine Tumor Surgery
Spine tumors can significantly affect the quality of life, causing pain, neurological deficits, and even disability if left untreated. Dr. Navneet Agrawal specializes in diagnosing and treating a wide range of spinal tumors, including:
Benign tumors such as osteomas and meningiomas
Malignant tumors like spinal metastases and chordomas
Primary spinal cord tumors such as ependymomas and astrocytomas
His proficiency in advanced surgical techniques, such as minimally invasive spine surgery (MISS) and robotic-assisted procedures, ensures optimal outcomes for his patients.
Comprehensive Patient Care
What sets Dr. Navneet Agrawal apart is his holistic approach to patient care. From initial consultation to post-surgical recovery, he ensures that every patient receives personalized attention. Dr. Agrawal collaborates with a multidisciplinary team of oncologists, radiologists, and physiotherapists to develop tailored treatment plans that prioritize both physical and emotional well-being.
Achievements and Contributions
Dr. Agrawal’s contributions to the field of spine surgery are commendable. Highlights of his career include:
Performing hundreds of successful spine tumor surgeries with minimal complications.
Receiving accolades for his research on innovative surgical techniques.
Conducting workshops and seminars to educate aspiring spine surgeons.
Actively participating in community awareness programs about spinal health.
State-of-the-Art Facilities
Dr. Navneet Agrawal practices at one of Jaipur’s premier medical institutions, equipped with cutting-edge technology for diagnostics and surgical interventions. Patients benefit from the latest imaging tools, intraoperative monitoring systems, and advanced rehabilitation facilities.
Why Choose Dr. Navneet Agrawal?
Extensive Experience: Over a decade of expertise in spine tumor surgery.
Innovative Techniques: Proficiency in minimally invasive and robotic-assisted surgeries.
Patient-Centric Care: Compassionate and personalized approach.
Positive Outcomes: High success rates with excellent post-operative recovery.
Testimonials
Many patients have shared their success stories after undergoing treatment with Dr. Navneet Agrawal. Here’s what some of them have to say:
“Dr. Agrawal’s expertise and kindness gave me a new lease on life. I am pain-free and back to my routine!” - Rajesh S.
“Choosing Dr. Navneet Agrawal was the best decision. His treatment restored my mobility and confidence.” - Pooja M.
Contact Dr. Navneet Agrawal
If you’re seeking expert care for spine tumors, Dr. Navneet Agrawal is here to help. Book a consultation and take the first step toward recovery.
Location: [Insert Clinic/Hospital Address]
Contact: [Insert Phone Number/Email]
Website: [Insert Website Link]
Experience world-class spine tumor treatment in Jaipur with Dr. Navneet Agrawal—your trusted partner in spinal health.
0 notes
Text
Spine Tumor Surgeon in Jaipur: Advanced Care for Complex Conditions
Spine tumors, whether benign or malignant, pose significant health risks that can impact the spinal cord, nerves, and overall function of the spine. These tumors require specialized treatment and often surgical intervention to prevent further complications such as pain, paralysis, or neurological damage. In Jaipur, patients with spine tumors can find expert care from top spine tumor surgeons who utilize advanced techniques to ensure safe and effective outcomes.

Understanding Spine Tumors
A spine tumor is an abnormal growth that develops within or near the spinal column. These tumors can either be primary, originating in the spine, or secondary (metastatic), meaning they spread from other parts of the body. While benign tumors may not be cancerous, they can still cause significant pain and neurological issues by pressing on nerves or the spinal cord. Malignant tumors are cancerous and may require more aggressive treatment, including surgery, chemotherapy, and radiation.
Common types of spine tumors include:
Intradural-extramedullary tumors: These tumors develop inside the spinal cord’s dura mater but outside the nerves. Examples include meningiomas and schwannomas.
Intramedullary tumors: Found within the spinal cord itself, these tumors, such as astrocytomas or ependymomas, can lead to serious neurological damage if not treated promptly.
Extradural tumors: These grow outside the dura mater and often originate in the bones of the spine, such as metastatic tumors.
Signs and Symptoms of Spine Tumors
Spine tumors can cause various symptoms depending on their location and size. Patients may experience:
Back or neck pain: Persistent pain that worsens over time and does not respond to conservative treatments can be a sign of a spine tumor.
Neurological symptoms: Numbness, tingling, or weakness in the arms or legs are common symptoms if the tumor compresses nerves.
Loss of bladder or bowel control: In severe cases, tumors can interfere with nerve signals, leading to incontinence.
Difficulty walking or maintaining balance: Tumors pressing on the spinal cord can affect motor functions.
The Role of a Spine Tumor Surgeon
A spine tumor surgeon specializes in diagnosing and treating tumors located in or around the spinal column. These surgeons have in-depth knowledge of both neurosurgery and orthopedic surgery, allowing them to address the complexities of spine tumor cases.
In Jaipur, top Spine Tumor Surgeon in Jaipur utilize a combination of advanced imaging technology, minimally invasive techniques, and traditional surgical methods to treat tumors effectively. The goal of surgery is to remove the tumor while preserving as much of the spinal cord and nerve function as possible. In some cases, complete tumor removal may not be possible, but surgeons can reduce the size of the tumor to alleviate symptoms and improve the patient’s quality of life.
Advanced Surgical Techniques
Spine tumor surgery requires precision and expertise. Surgeons in Jaipur employ the following advanced techniques to ensure successful outcomes:
Minimally invasive spine surgery: This approach involves smaller incisions, reducing recovery time and minimizing the risk of infection.
Microsurgery: Using high-powered microscopes, surgeons can perform intricate procedures to remove tumors without damaging surrounding tissues.
Stereotactic surgery: This cutting-edge technique uses 3D imaging to guide the surgeon during the procedure, allowing for greater accuracy and safety.
0 notes
Text
Types of Cancer that Develop in Children
Cancer in children is a rare but serious health risk. Pediatric cancers are primarily caused by genetic mutations or developmental processes, as opposed to adult malignancies, which are frequently influenced by environmental factors and lifestyle choices. Despite the hurdles, many juvenile malignancies are curable, particularly with early detection and sophisticated treatment. Understanding the many forms of malignancies that typically affect children can help parents and caregivers become more aware of the symptoms and intervene sooner. For families wanting the greatest level of care, selecting the best Pediatric hospital in Jaipur is vital in providing children with the specific attention they require during this critical period.
Common Types of Childhood Cancers
There are several types of cancer that commonly affect children. Each type presents unique challenges and requires specific treatments tailored to the child’s age, size, and overall health. Below is an overview of the most frequent childhood cancers:
1. Leukemia
Leukemia is the most common type of cancer in children, accounting for about 30% of all pediatric cancers. This cancer starts in the bone marrow, where blood cells are produced. The two main types of leukemia in children are:
Acute Lymphoblastic Leukemia (ALL): This is the most common form of leukemia in children. It occurs when the bone marrow produces too many immature white blood cells, which crowd out normal cells and lead to various symptoms like fatigue, fever, and bone pain.
Acute Myeloid Leukemia (AML): Though less common than ALL, AML is a more aggressive form of leukemia that affects both the bone marrow and blood, leading to infections, anemia, and easy bruising or bleeding.
Symptoms of leukemia often include fatigue, frequent infections, easy bruising, swollen lymph nodes, and unexplained weight loss. Early diagnosis and treatment, often including chemotherapy, can lead to successful outcomes.
2. Brain and Central Nervous System (CNS) Tumors
Brain tumors are the second most common type of childhood cancer. They can occur in various parts of the brain and spinal cord, and their symptoms depend on the tumor's location and size. The most common types of brain tumors in children include:
Medulloblastoma: This is the most common malignant brain tumor in children. It typically arises in the cerebellum, the part of the brain responsible for balance and coordination.
Gliomas: These tumors originate from glial cells in the brain and spinal cord. There are several subtypes, including astrocytomas and ependymomas, which can be benign or malignant.
Symptoms of brain tumors include headaches, nausea, vomiting, balance problems, seizures, and vision or hearing changes. Surgery, radiation therapy, and chemotherapy are commonly used treatments, and the prognosis depends on the tumor’s type and location.
3. Neuroblastoma
Neuroblastoma is a cancer that arises from immature nerve cells in young children, usually under the age of five. It typically starts in the adrenal glands on top of the kidneys, although it can also develop in the neck, chest, abdomen, or spine.
Neuroblastoma symptoms vary depending on where the tumor is located, but they may include abdominal pain, a lump in the abdomen or neck, weight loss, and difficulty breathing or swallowing. Neuroblastoma can be aggressive, although therapeutic options such as surgery, chemotherapy, radiation, and stem cell transplants have led to higher survival rates.
4. Wilms’ Tumor
Wilms’ tumor, or nephroblastoma, is a cancer of the kidneys that primarily affects children aged 3 to 4. It accounts for about 5% of all pediatric cancers. Wilms’ tumor usually manifests as a painless swelling or lump in the abdomen, sometimes accompanied by fever, nausea, or blood in the urine.
Most children with Wilms' tumor respond well to treatment, which typically involves surgery to remove the tumor, followed by chemotherapy and sometimes radiation. The prognosis is often excellent, especially when diagnosed early.
5. Lymphomas
Lymphomas are cancers of the lymphatic system, which is part of the immune system. There are two main types of lymphoma in children:
Hodgkin’s Lymphoma: This type of lymphoma is characterized by the presence of Reed-Sternberg cells and is more common in adolescents. Symptoms include swollen lymph nodes, fever, night sweats, and weight loss.
Non-Hodgkin’s Lymphoma (NHL): NHL is more common in younger children and tends to grow more aggressively than Hodgkin's lymphoma. Symptoms often include abdominal pain, swelling, and difficulty breathing.
Both types of lymphoma are treated with chemotherapy, and the success rate is high, especially for early-stage Hodgkin's lymphoma.
6. Rhabdomyosarcoma
Rhabdomyosarcoma is a cancer that develops in the soft tissues, particularly in the muscles that control voluntary movements. It can occur anywhere in the body but is most commonly found in the head, neck, bladder, and arms or legs. Symptoms vary depending on the location but may include pain, swelling, and the presence of a lump.
This cancer is typically treated with surgery, chemotherapy, and radiation therapy, and the prognosis depends on the tumor’s location and the extent of its spread.
7. Retinoblastoma
Retinoblastoma is a rare cancer of the retina, the light-sensitive tissue at the back of the eye. It primarily affects children under the age of 5. The most common sign of retinoblastoma is a visible whiteness in the pupil when light is shone into the eye, often noticed in photographs.
Treatment for retinoblastoma may include laser therapy, cryotherapy, chemotherapy, or, in severe cases, removal of the affected eye. Early diagnosis is key to preserving vision and preventing the spread of cancer.
8. Bone Cancers
Two main types of bone cancer affect children:
Osteosarcoma: The most common type of bone cancer in children, osteosarcoma usually develops in the long bones, such as the arms and legs, and is more prevalent in teenagers during growth spurts.
Ewing Sarcoma: This cancer can develop in both the bones and surrounding soft tissues and tends to affect adolescents and young adults.
Symptoms of bone cancer include bone pain, swelling, and fractures. Treatment usually involves surgery, chemotherapy, and sometimes radiation.
Conclusion
Childhood cancers, though rare, pose significant challenges for children and their families. Early detection and prompt, effective treatment can greatly improve the chances of survival and recovery. It’s important for parents to stay vigilant about unusual symptoms and seek medical care if they suspect something is wrong. For those navigating the complex world of pediatric cancer, selecting the best hospital in Jaipur for cancer treatment ensures that your child receives the best possible care, helping them on the road to recovery and giving them a brighter, healthier future.
0 notes
Text
Chemotherapy for Brain Cancer: Understanding the Options

Brain cancer, a devastating diagnosis, often involves a complex treatment regimen that may include chemotherapy. This article aims to provide a comprehensive overview of chemotherapy options for brain cancer, tailored for patients and their families.
What is Chemotherapy?
Chemotherapy is a cancer treatment that uses drugs to kill cancer cells with Neuro Surgery oncology. These drugs can be administered intravenously, orally, or directly into the brain. The goal of chemotherapy is to shrink tumors, prevent cancer cells from spreading, and improve the overall quality of life.
Types of Chemotherapy for Brain Cancer
There are several types of chemotherapy drugs used to treat brain cancer. The specific type chosen depends on the type and stage of the cancer, as well as the patient's overall health. Some common types include:
Temozolomide: This oral medication is often used to treat glioblastoma, the most common type of primary brain cancer.
Carboplatin: This intravenous drug is sometimes used in combination with radiation therapy for brain tumors.
Lomustine: This oral medication can be used to treat various types of brain cancer, including astrocytomas and oligodendrogliomas.
Bevacizumab: This monoclonal antibody targets a protein that helps cancer cells grow and spread. It is sometimes used in combination with other treatments for certain types of brain cancer.
How Chemotherapy is Administered for Brain Cancer
The way chemotherapy is administered depends on the type of drug and the patient's condition. Some common methods include:
Intravenous (IV) infusion: The drugs are injected directly into a vein.
Oral administration: The drugs are taken by mouth in pill or capsule form.
Intrathecal injection: The drugs are injected directly into the cerebrospinal fluid, which surrounds the brain and spinal cord.
Side Effects of Chemotherapy for Brain Cancer
Chemotherapy can cause side effects, which can vary depending on the type of drug and the individual's response. Some common side effects include:
Fatigue
Nausea and vomiting
Hair loss
Mouth sores
Increased risk of infection
Changes in cognitive function
It's important to discuss any side effects with your healthcare team. They can recommend strategies to manage these symptoms and improve your overall quality of life.
Factors Affecting Chemotherapy Effectiveness
Several factors can influence the effectiveness of chemotherapy for brain cancer, including:
Type and stage of cancer
Overall health of the patient
Sensitivity of the cancer cells to the chemotherapy drugs
Combination with other treatments
Chemotherapy in Combination with Other Treatments
Chemotherapy is often used in combination with other treatments, such as surgery and radiation therapy. This can improve the overall effectiveness of the treatment and help to control the cancer.
Challenges of Treating Brain Cancer with Chemotherapy
Treating brain cancer with chemotherapy can present unique challenges due to the blood-brain barrier, a protective layer that surrounds the brain. This barrier can make it difficult for chemotherapy drugs to reach the cancer cells. However, newer treatments and research are exploring ways to overcome this obstacle.
Future Directions in Chemotherapy for Brain Cancer
Research is ongoing to develop new chemotherapy drugs and treatment strategies for brain cancer. This includes:
Targeted therapies that specifically target cancer cells without harming healthy cells
Immunotherapy that stimulates the immune system to fight cancer cells
Combination therapies that combine different types of treatments to improve effectiveness
Conclusion
Chemotherapy is an important option for many patients with brain cancer with Neuro Surgery oncology . While it can have side effects, it can also be effective in controlling the cancer and improving the quality of life. If you or someone you know is facing a diagnosis of brain cancer, it's important to discuss the available treatment options with your healthcare team. By understanding the benefits, risks, and challenges of chemotherapy, you can make informed decisions about your care.
0 notes
Text
Glioma Brain Cancer: Types, Symptoms, Causes & Treatments
Glioma Brain Cancer is a type of cancer that originates in the brain. It is a highly aggressive and invasive form of cancer that affects the glial cells, which provide support for the neurons in the brain. Gliomas can occur in any part of the brain and can vary in grade, ranging from low-grade to high-grade tumors. The symptoms of glioma brain cancer can vary depending on the location and size of the tumor but can include headaches, seizures, changes in personality, and difficulty with coordination.
Types of Brain Cancer Glioma can be classified into several different types based on their cellular origin and characteristics. These include astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas. Astrocytomas are the most common type of glioma, arising from astrocytes, a type of glial cell. Oligodendrogliomas develop from oligodendrocytes, another type of glial cell, and are known for their distinct appearance under a microscope.
Gliomas are often asymptomatic in their early stages, which can make early detection challenging. However, as these tumors grow and put pressure on surrounding brain tissue, certain signs and symptoms may begin to manifest. These can include persistent headaches, nausea and vomiting, seizures, difficulty with speech or vision, and changes in mood or behavior. It is important to note that these symptoms can vary depending on the location of the glioma within the brain.
Treatment for glioma brain cancer is multifaceted and depends on several factors, including the type and grade of the tumor, as well as the patient's overall health. The main treatment options for glioma brain cancer include surgery, radiation therapy, and chemotherapy. Surgery is often the first step in treating gliomas, as it allows for the removal of as much of the tumor as possible. This can help alleviate symptoms and improve the patient's quality of life. For more information about Glioma brain cancer, visit our website or the below-mentioned source link.
Source: Glioma brain cancer
4 notes
·
View notes
Text
Astrocytic Tumors Brain tumor is one of the most lethal forms of cancers with more than 13,000 deaths every year in the United States. Though we are still a long way from developing medical interventions that promise total recovery, advancements in the diagnostic methods such as MRS, ultrasonic aspiration and in surgical procedures such as intraoperative neuronavigation, Gamma Knife radiosurgery, etc., have improved the precision for the surgeon and outcome for the patient to a significant extent. It is hoped that our increasing understanding of the molecular pathology of the disease propelled by the huge amount of research devoted to the field would lead to developing a successful treatment plan for astrocytoma and all other forms of brain tumors in the near future. Introduction Brain tumor is one of the dangerous forms of cancer and in the United States alone more than 200,000 people are affected by it every year. Of these, primary brain tumors account for around 40,000 cases. Statistics indicate that approximately 13,000 people die of brain tumor every year making up 2% of all cancer related deaths in the U.S. Tumors are classified as primary or secondary based on the location of their origin. Cancers that originate within the brain cells are called primary tumors and those that are derived from other parts of the body into the brain are called metastatic or secondary brain tumors. Glial cells are the cells that nourish, insulate and support the neurons. They also form part of the blood brain barrier. Tumors derived from the glial cells account for 44.4% of all primary forms of brain tumor. Astrocytoma or tumors derived from the astrocyte cells account for 11.3% of all primary brain and CNS tumors and 21.6% of all gliomas. Let us have a brief overview of Astrocytoma, the condition, it's pathogenesis, diagnosis and treatment methods. The Glial Cells The brain is made up of two important cell types namely the neurons and the glial cells. While the neurons have action potential and constitute the main functional mechanism for the brain the glial cells are by no means less important. In fact the glial cells exceed neurons in number by 10 to 50 times. There are different types of glial cells namely astrocytes, oligodendrocytes and ependymal cells. The astrocytes are star shaped cells, which nourish, insulate and support the neurons. Astrocytes also perform cleanup operations by digesting dead neuron cells. Glioma is a collective term that refers to tumors that originate from these glial cells. Astrocytomas, Ependymomas, Oligodendrogliomas are the different types of gliomas derived from the corresponding cell types. Tumor Grades Besides the basic classification of malignant and benign forms, tumors are also classified based on the rate of development and appearance. The WHO classifies grade 1 tumor as normal under the microscope and with a very slow growth rate. These tumors can be effectively managed by surgery. Grade 2 tumors have a slightly faster growth rate and cellular abnormalities are clearly visible under microscopic observation. These tumors can affect neighboring cells and carry the risk of developing into higher-grade tumors. Grade 3 tumors are classified as malignant tumors, which grow rapidly and affect neighboring tissues at a fast rate. Grade 4 tumors are the most deadly in terms of their growth. They spread very fast and affect a large area. They are called necrotic tumors as they have dead cells in the center and they grow new blood vessels to sustain their rapid proliferation. Astrocytomas are classified into four types based on the above-mentioned grading. Pilocytic Astrocytomas are first grade astrocytomas that predominantly affect pediatric patients. Astrocytes are found along with rosenthal fibers and eosinophilic granular bodies. The lesions that appear in the brain tissue are referred to as "juvenile pilocytic astrocytoma." This condition accounts for 85% of cerebellar tumor. The preferred sites for this tumor include the cerebellum, cerebral hemispheres, ganglia, thalamus and the optic nerve. Fibrillary Astrocytoma is a grade-2 astrocytoma and it is not circumscribed. It is well differentiated and affects adjoining cells and is a tumor of the fibrillary or gemistocytic neoplastic astrocytes. In around 60% of the Patients diagnosed with this condition P53 mutations have been observed. It is found that this type of astrocytoma is common among patients who have Li-Fraumeni syndrome. (patients with inherited P53 mutation) Anaplastic Astrocytomas is a grade 3 astrocytoma and is a malignant form. This type shows increased cellularity and distinct nuclear atypia. This tumor is characterized by high TP53 mutations. Typically in this tumor, most of the genes that are concerned with cell progression are altered. The Glioblastoma Multiforme, a grade 4 and most malignant form of astrocytoma is anaplastic and composed of pleomorphic astrocytic tumor cells showing intense mitotic activity. Glioblastoma is the most common form of brain tumor accounting for 12% to 15% of all tumors and around 60% of all astrocytic tumors. There are two types of Glioblastoma as Dr. Vinay says, "One type begins as a low- or intermediate-grade astrocytoma and changes into a glioblastoma," the other type, known as the denovo form, seems to start out as a glioblastoma. This seems to be due to the differences in the genetic changes that trigger the growth of these tumors." it predominantly affects the cerebral hemispheres and has a high incidence rate for people between 45 and 70 years of age. The GBM is also one of the most complex forms of tumor where a single gene cannot be implicated as the precursor. To quote Dr. Vinay again, "there does not appear to be a single genetic basis that could explain the disease that we have been able to find. While genetics seems to play a role, it doesn't seem to be a 'one-hit' problem, like certain leukemias that can be traced to one gene; it's more like multiple hits that take place over a period of time." Amplification of the EGFR (epidermal growth factor receptor) is found in approximately 40% of primary gliblastoma cases. Mutations of the PTEN gene are also observed in 45% of primary gliblastomas. Pathogenesis There is no clearly identified molecular pathology for astrocytoma. Research is still focused on understanding the molecular pathologies underlying astrocytoma. However, research has indicated the following genetically derived pathologies. The following genes: PTEN/MMAC1, DMBT1 (deleted in malignant brain tumor-1), EGFR, TP53, P16, PDGFR, and retinoblastoma cell-cycle regulatory gene have all been indicated in the onset of astrocytoma. Though, today, alterations in these genes are well-known, the cause for these abnormal gene alterations remain unknown. The most commonly identified causes are the deletion of tumor suppressing genes such as p53, retinoblastoma, p16 as well as the addition of tumor promoting genes such as PDGFR, and EGFR. Mutation to the P53 tumor suppressor gene is an important factor in tumor development. Studies have shown that the P53 mutations are the most common among humans and hence carry a risk potential for developing cancers. Since the P53 gene is responsible for cell cycle regulation, which includes induction of apoptosis, aberration in the gene results in uncontrolled cell growth. Studies have also implicated RNA binding proteins in the pathogenesis of astrocytoma. The link between over expression of tyrosine kinase (which is a chief regulator found in malignant astrocytes) and the RNA posttranscriptional modifications are being closely studied. in Glioblastma multiforme (GBM), the most lethal form or grade 4 astrocytoma, researchers have observed aberrations on chromosome 10 resulting in the loss of tumor suppressing genes such as PTEN/MMAC1 along with other similar genes that regulate P. I3 Kinase and PKB/Akt pathways. Animal Studies have also attested that the P. I3 kinase (phosphoinositide-3-kinase) in particular has a vital role in defining and regulating the number and size of the cells in tissues. Further, molecular studies have also revealed the overexpression of tumor promoting genes such as EGFR and other Growth factor receptors that activate P21 - RAS signalling pathways. Also deletion of PTEN and a resultant increase in phosphorylated PKB/Akt has been shown to result in an increase in cell size. Hence downregulation of PI3 Kinase, PTEN, overexpression of EGFR and PFGFR, are some of the possible molecular pathologies. Symptoms and Diagnosis There are many different symtoms associated with astrocytoma or any type of brain tumor in general. Because there is an increase in intra-cranial pressure due to the increased cell mass, headache is a commonly observed symptom. Nausea, vomitting, dementia, changes in personality and mood swings are also observed. However, symptoms are mostly associated with the position of the tumor within the brain. For example, tumor in the occipictal lobe would result in visual hallucinations and impairment while a tumor positioned in the parietal lobe will lead to impaired motor functions. Diagnosis of astrocytoma involves a complete examination by the physician followed by a series of tests such as MRI, CT scan, angiogram and biopsy. The MRI uses a magnet, radio waves and computer to create high quality 3d images of the brain. The MRI is considered the best choice as it has a 81% to 100% specificity as compared to the CT scan which has 72% to 100% specificity. Using MRS chemical composition of the tumor and the metabolite intensities can also be ascertained along with the morphological characterisitcs. Thus MRI provides better information which is useful in grading the tumor. For grade 4 astrocytoma's spectroscopic studies reveal high Cho, high lipid, high lactate and low NAA values. However, the MRI testing is time consuming (40 to 90 minutes) and is problematic for claustrophobic patients. Biopsy of the affected brain tissue will also help in determining the nature of the abnormal tissue growth. Treatment Treatment for astrocytoma includes, surgery, chemotherapy, radiation and gluco corticoid medication. Treatment improves the survival rates for patients and the type of treatment depends on the growth and location of the tumor. First grade tumors such as Pilocytic Astrocytomas are easily treated by resection. In most cases removal of the affected part would be sufficient. However, if the location of the tumor makes surgery an impossible choice then the condition is treated by chemotherapy and radiotherapy. In fibrillary, anaplastic astrocytoma and Glioblastoma complete removal by surgery is followed by chemotherapy and radiation. Total cure is possible for Pilocytic Astrocytomas after surgery while the prognosis for fibrillary astrocytoma depends on whether or not the tumor cells are transformed into more malignant types. Also recurrence is high in fibrillary astrocytoma. With the advancements in medical technology such as intraoperative neuronavigation that allows the surgeon to see the surgical region on the computer screen, and the use of high power microscopes to magnify the surgical zone, it is possible to limit damage to adjacent healthy tissues while doing a tumor resection. Radiation therapy may be both external and internal. In the later case, radioactive materials are implanted near the tumor zones. It is now common to use biodegradable BCNU polymer wafer implants for radiation therapy. Also, the use of scalpel for tissue extraction can be eliminated by using the 'ultrasonic aspiration' method. Ultrasonic waves are focused on the tumor area to break it down and the fragments are removed by suction. Radiosurgery Stereotactic radiosurgery is a non-invasive form of therapy, which can be done in a session by a neurosurgeon. The aim of the therapy is to destroy the tumor cells by concentrating a series of cobalt 60 beams from different angles onto a spot. Since individual beams are not strong enough to destroy healthy cells the therapy does not affect healthy cells that is passes thorough but only affects the area on the brain where all the beams converge (the tumor zone). However, this therapy has its limitations and only an area of 4 cm can be treated at any one time so it might involve multiple sessions. Radiosurgery is typically recommended for patients who do not have the need for surgical intervention. However, this therapy is also used post surgery to remove traces of tumor cells that might still exist. Though the radiation does not destroy healthy cells, multiple sessions of radiotherapy are not recommended for children in view of the possible long-term damage to a brain which is still in the developmental stage. Chemotherapy Chemotherapy is a much older form of treatment and involves a combination of drugs to destroy the cancerous cells. The usefulness of drugs in the treatment of tumors is largely affected by the 'blood brain barrier' that filters of most toxic substances from entering the brain. Chemotherapy is usually given as a secondary therapy after surgery and alongside radiotherapy. Chemotherapy requires that the patient be healthy enough for the treatment. Drugs can be given orally or intravenously. Glucocorticoids are one of the main pharmacological interventions in providing symptomatic relief for patients affected by brain tumor. The edema that results from brain tumor increases the intra-cranial pressure and gives severe forms of headache. Glococorticoids and other cortisone drugs help in alleviating the symptoms by reducing the water level in the 'peritumoral zone' of the edema. Conclusion Glial tumors are the most common and dangerous forms of brain tumors. Treatment by a combination of methods may improve the prognosis and the quality of life for the patient. While in some tumors such as the Pilocytic Astrocytomas and Fibrillary Astrocytomas, total recovery maybe possible we are still a long way from providing complete relief for all the different types of astrocytomas. Treatments for astrocytoma may also result in serious side effects as it involves the brain. Advancements in the diagnostic methods such as MRS, ultrasonic aspiration and in surgical procedures such as intraoperative neuronavigation, Gamma Knife radiosurgery, etc. have improved the precision for the surgeon and outcome for the patient to a significant extent. However, significant advancements in molecular biology could only yield us the victory over the battle with tumor. It is hoped that with the huge volume of research that is currently underway in understanding the pathology of the disease it would not be long before successful treatment and prevention methods could be developed for astrocytoma and all other forms of brain tumors. Bibliography Capodano AM. Nervous system: Astrocytic tumors. Atlas Genet Cytogenet Oncol Haematol. November 2000. Available at, http://AtlasGeneticsOncology.org/Tumors/AstrocytID5007.html BTS, "Brain Tumor Facts & Statistics," Accessed Nov 18th 2007, available at http://www.tbts.org/itemDetail.asp?categoryID=384&itemID=16535 Karen T. Barker and Richard S. Houlston, "Overgrowth syndromes: Is dysfunctional P. 13 Kinase signalling a Unifying mechanism," European Journal of Human Genetics (2003) 11, 665-670. Available online at, http://www.nature.com/ejhg/journal/v11/n9/full/5201026a.html Medscape, " a Review of Astrocytoma Models: Molecular pathologies of Astrocytoma," Neurosurgical Focus 8(4), 2000 eMedicine, "Astrocytoma, Brain," Accessed on Noiv 18th 2007, available at http://www.emedicine.com/radio/topic60.htm Nobuaki Ishii and N. de Tribolet, "Are p53 mutations and p53 over expression prognostic factors for astrocytic tumors? Critical reviews in Neurosurgery, vol 8 / no 5, Sept 1998. Pamela a. Silver PhD, "RNA Binding Proteins in the Progression of Adult Astrocytic Tumors," Accessed Nov 18th 2007, Available online at, http://www.goldhirshfoundation.org/project_summaries_2002.htm NCI, "Adult Brain Tumors: Classification," Accesed Nov 18th 2007, available at http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/285.cdr#Section_285 Sosuke Minamikawa et.al,' Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging ', Neuroradiology, Vol 46, No 10, Oct 2004 CancerWise, "Glioblastoma Brain Tumors Puzzle Doctors: Studies Continue on How to Treat Formidable Disease," Accessed 19th Nov 2007, Available at, http://www.cancerwise.org/december_2002/display.cfm?id=dbb59002-1a31-48c6-b6823d1c45bff4b8&method=displayfull&color=green IRSA, "Astrocytomas," Accessed Nov 18th 2007, available at http://www.irsa.org/astrocytoma.html ISCID, "The Glial Cell," Accessed Nov 18th 2007, available at http://www.iscid.org/encyclopedia/The_Glial_Cell Read the full article
0 notes
Text
Types, Risk Factors, Symptoms, and Treatment of Brain Tumor
Brain tumors are complex and varied, impacting the central nervous system in diverse ways. They can occur in any part of the brain and affect various functions depending on their location, size, and type. Understanding the types, risk factors, symptoms, and treatment options for brain tumors is crucial for early diagnosis and effective management.
At GS Super Speciality Hospital, we offer comprehensive care for brain tumor patients, leveraging advanced medical technologies and expert neurology and neurosurgery teams to provide the best possible outcomes.
Types of Brain Tumors:
Brain tumors are categorized into two main types: primary and secondary. Each category includes various tumor types with distinct origins and characteristics.
Primary Brain Tumors:
Primary brain tumors originate directly in the brain or surrounding tissues. Common types include:
Gliomas: Arising from glial cells that support and protect nerve cells, gliomas include:
Astrocytomas: These tumors develop from astrocytes, a type of glial cell. They are classified into grades I-IV, with higher grades indicating more aggressive and malignant forms.
Oligodendrogliomas: Tumors that originate from oligodendrocytes, which are responsible for producing myelin, the nerve cell's protective covering.
Ependymomas: Develop from ependymal cells lining the brain's ventricles and the spinal cord. These tumors can affect cerebrospinal fluid flow.
Meningiomas: These tumors start in the meninges, the protective membranes surrounding the brain and spinal cord. While often benign, they can cause significant symptoms depending on their location and size.
Medulloblastomas: Primarily found in children, medulloblastomas are highly malignant tumors that arise in the cerebellum, which controls coordination and balance.
Pituitary Tumors: These tumors form in the pituitary gland, which regulates hormones throughout the body. They can disrupt hormone balance and lead to various systemic symptoms.
Secondary Brain Tumors:
Secondary brain tumors, or metastatic brain tumors, result from cancer cells spreading from other parts of the body. Common origins include:
Lung Cancer: The most frequent source of brain metastases, lung cancer cells can spread to the brain.
Breast Cancer: Another common origin of brain metastases, often affecting women with a history of breast cancer.
Melanoma: Skin cancer that can spread to the brain, making early detection and treatment crucial for managing overall prognosis.
Understanding these tumor types is essential for diagnosis, treatment planning, and managing the impacts of brain tumors on overall health.
Risk Factors for Brain Tumors:
Several factors can increase the likelihood of developing a brain tumor, although not everyone with these risk factors will develop the condition. Understanding these risk factors can help with early detection and prevention. Key risk factors include:
Genetic Factors:
Family History: Inherited genetic conditions can heighten the risk of brain tumors. Examples include:
Neurofibromatosis: A genetic disorder that leads to the growth of benign and malignant tumors on nerve tissues.
Li-Fraumeni Syndrome: A rare genetic disorder that increases susceptibility to multiple cancers, including brain tumors.
Genetic Mutations: Certain mutations, particularly in tumor suppressor genes, may predispose individuals to brain tumors.
Environmental Factors:
Exposure to Radiation: Previous exposure to radiation therapy, particularly in the head or neck area during childhood, significantly raises the risk of brain tumors.
Chemical Exposures: Some studies suggest that long-term exposure to industrial chemicals or solvents may increase the risk of brain tumors. However, evidence remains inconclusive.
Other Factors:
Age: Although brain tumors can occur at any age, they are more frequently diagnosed in children and adults over the age of 60.
Gender: Certain brain tumors are more common in one gender than the other. For example:
Meningiomas: More common in women.
Gliomas: More prevalent in men.
These risk factors can serve as a guide for understanding susceptibility but do not guarantee the development of brain tumors.
Managing Life after Treatment:
Post-treatment care is essential for ensuring long-term health and quality of life for brain tumor survivors. Effective management includes:
Regular Follow-Up Appointments:
Tumor Monitoring: Routine imaging and assessments to check for any signs of tumor recurrence.
Side Effect Management: Ongoing evaluation to address and manage any lingering or new side effects from treatment.
Rehabilitation Services:
Physical Therapy: Helps restore movement, strength, and coordination, improving daily functioning and mobility.
Occupational Therapy: Aims to enhance the ability to perform everyday activities and adapt to any changes in physical or cognitive abilities.
Speech Therapy: Supports recovery of communication skills and cognitive function, particularly if affected by surgery or treatment.
Psychological Support:
Counseling: Provides emotional support to help patients cope with the psychological impacts of brain tumor diagnosis and treatment.
Support Groups: Offers a community of individuals with similar experiences, providing shared understanding and encouragement.
These strategies ensure that patients receive comprehensive care and support to facilitate their recovery and maintain a good quality of life after treatment.
Symptoms of Brain Tumors:
Brain tumor symptoms can vary significantly depending on the type, size, and location of the tumor. Early recognition of these symptoms is crucial for prompt diagnosis and treatment.
General Symptoms:
Headaches: Persistent or worsening headaches, particularly those that are more severe in the morning or become progressively worse over time.
Nausea and Vomiting: Unexplained nausea and vomiting, often occurring without any apparent cause, and worsening as the tumor grows.
Neurological Symptoms:
Seizures: New-onset seizures or changes in existing seizure patterns are often one of the first signs of a brain tumor.
Cognitive Changes: Memory loss, confusion, difficulty concentrating, or changes in problem-solving abilities.
Speech or Vision Changes: Trouble speaking, understanding language, blurred vision, or sudden loss of vision.
Physical Symptoms:
Weakness or Numbness: Weakness, numbness, or tingling in the arms or legs, usually on one side of the body.
Coordination Issues: Difficulty with balance, coordination, or walking, making everyday tasks more challenging.
Personality or Behavioral Changes: Changes in personality, mood swings, increased irritability, or even aggression.
Diagnosing Brain Tumors at GS Super Speciality Hospital:
In the Top 10 private hospitals in Uttar Pradesh at GS Super Speciality Hospital, advanced diagnostic tools are used to confirm the presence and nature of brain tumors, ensuring accurate treatment planning.
Imaging Tests:
Magnetic Resonance Imaging (MRI): Provides high-resolution images to locate and analyze brain tumors.
Computed Tomography (CT) Scan: Offers a detailed view of the tumor’s size and impact on surrounding structures.
Positron Emission Tomography (PET) Scan: Assesses tumor activity and potential spread.
Biopsy:
Surgical Biopsy: Tumor tissue is sampled during surgery.
Needle Biopsy: A needle extracts a small tissue sample for analysis.
Other Diagnostic Tests:
Lumbar Puncture: Examines cerebrospinal fluid for cancer cells.
Genetic Testing: Identifies specific genetic mutations linked to the tumor.
Treatment Options for Brain Tumors:
Treatment for brain tumors is highly individualized, aiming to effectively target the tumor while preserving brain function and overall health. A comprehensive treatment plan may include one or more of the following options:
Surgery:
Surgery is often the first line of treatment for brain tumors, aiming to remove as much of the tumor as possible while minimizing damage to surrounding brain tissue. Surgical options include:
Craniotomy: This procedure involves removing a portion of the skull to access and excise the tumor. The extent of removal depends on the tumor’s location, size, and type.
Stereotactic Surgery: A minimally invasive technique that uses precise imaging guidance to target and remove the tumor with high accuracy, reducing damage to healthy tissue.
Radiation Therapy:
Radiation therapy uses high-energy rays to destroy cancer cells and shrink tumors. It is often used in conjunction with surgery or as a primary treatment for tumors that cannot be surgically removed. Types include:
External Beam Radiation: Radiation is delivered from outside the body using a machine that targets the tumor.
Stereotactic Radiosurgery: This non-invasive technique employs focused radiation beams to treat tumors with extreme precision, often used for small or inoperable tumors.
Chemotherapy:
Chemotherapy involves using drugs to kill cancer cells throughout the body. This treatment can be administered orally or intravenously and is often used in combination with surgery and radiation. It is particularly useful for malignant tumors and metastatic brain tumors.
Targeted Therapy:
Targeted therapy involves drugs that specifically attack cancer cells based on their molecular and genetic profiles. These therapies can be more effective and have fewer side effects than traditional chemotherapy. They are used alone or alongside other treatments.
Immunotherapy:
Immunotherapy harnesses the body’s immune system to combat cancer cells. Treatments include:
Checkpoint Inhibitors: Drugs that help the immune system recognize and attack cancer cells.
Monoclonal Antibodies: Lab-made molecules that bind to cancer cells and mark them for destruction by the immune system.
Supportive Care:
Supportive care focuses on enhancing the patient’s quality of life throughout treatment. It includes:
Pain Management: Medications and therapies to manage pain.
Anti-Nausea Medications: Drugs to alleviate nausea and vomiting caused by treatments.
Cognitive and Emotional Support: Psychological support and therapies to help patients cope with cognitive changes and emotional stress.
These treatments are often combined to achieve the best possible outcome and are tailored to the specific characteristics of the tumor and the patient’s overall health.
Why Choose GS Hospital for Brain Tumor Treatment?:
10 Best Neurology Hospitals in Uttar Pradesh like GS Hospital stands out as a leading institution for the diagnosis and treatment of brain tumors, offering unparalleled care through advanced technology, expert medical teams, and a patient-centered approach. Here’s why GS Hospital is the top choice for brain tumor treatment:
Advanced Technology:
GS Hospital utilizes the latest technology to ensure precise diagnosis and effective treatment of brain tumors. The facility features:
State-of-the-Art Imaging Systems: Advanced MRI, CT scans, and PET scans for accurate tumor detection and monitoring.
Cutting-Edge Surgical Equipment: High-resolution microscopes, neuronavigation systems, and intraoperative imaging tools for precise tumor removal and minimal invasiveness.
Expert Medical Team:
The hospital boasts a multidisciplinary team of specialists dedicated to brain tumor care:
Neurosurgeons: Skilled in complex brain surgeries with a focus on preserving neurological function.
Neurologists: Experts in diagnosing and managing neurological symptoms associated with brain tumors.
Oncologists: Specialists in radiation and chemotherapy tailored to brain tumor types.
Radiologists: Professionals adept at interpreting advanced imaging and guiding treatment decisions.
Personalized Treatment Plans:
One of the Best Neurosurgery Hospitals in UP like GS Hospital provides individualized treatment plans that are:
Tailored to each Patient: Plans are based on the tumor’s type, location, and stage, as well as the patient’s overall health.
Collaborative Approach: Treatment strategies are developed through consultations among specialists to ensure comprehensive care.
Comprehensive Support Services:
In addition to medical treatment, GS Hospital offers extensive support services:
Psychological Support: Counseling and mental health services to help patients and families cope with the emotional impact of a brain tumor diagnosis.
Rehabilitation Services: Physical, occupational, and speech therapy to aid in recovery and enhance quality of life.
Counseling and Education: Resources and guidance for navigating treatment options and managing side effects.
Research and Innovation:
The hospital is at the forefront of medical research and innovation:
Ongoing Research: Participation in clinical trials and studies to explore new treatments and improve patient outcomes.
Access to Latest Therapies: Availability of cutting-edge therapies and experimental treatments as part of research programs.
Patient-Centered Care:
GS Hospital is dedicated to providing compassionate and patient-centered care:
Holistic Care: Emphasis on addressing the physical, emotional, and psychological needs of patients and their families.
Informed Decision-Making: Ensuring patients are well-informed and actively involved in their treatment decisions.
By combining advanced technology, expert care, personalized treatment, and comprehensive support, GS Hospital offers a holistic approach to brain tumor management, striving to achieve the best possible outcomes for its patients.
Conclusion:
Brain tumors are a serious and complex condition that requires prompt and effective management. Understanding the types, risk factors, symptoms, and treatment options is crucial for early diagnosis and successful treatment. At GS Super Speciality Hospital, our team of experts is dedicated to providing the highest level of care for brain tumor patients, utilizing advanced technologies and compassionate support to achieve the best possible outcomes.
#BrainTumor#Neurology#Neurologist#GSHospital#MedicalTechnologies#NeuroSurgery#Ghaziabad#UttarPradesh#India
0 notes
Text
Dr. Purvi Kadakia Kutty: Leading the Fight Against Cancer as Kharghar's Top Oncologist
Pediatric Oncology is a specialized branch of medicine that focuses on the diagnosis, treatment, and management of cancer in children and adolescents. It deals specifically with Child Oncologist in navi mumbai, which can vary significantly from cancers aggressiveness, and treatment approaches. Pediatric oncologists are medical experts who provide comprehensive care to young patients with cancer, working closely with a multidisciplinary team to ensure the best possible outcomes and quality of life for these young patients and their families.

Conditions Treated in Pediatric Oncology:
Pediatric oncologists manage various types of childhood cancers, which can affect different parts of the body. Some common childhood cancers treated in Pediatric Oncology include:
Leukemias: Cancers that affect the bone marrow and blood, including Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
Lymphomas: Cancers that arise from the lymphatic system, such as Hodgkin's lymphoma and Non-Hodgkin lymphoma.
Brain Tumors: Tumors that develop in the brain or spinal cord, including astrocytomas, medulloblastomas, and ependymomas.
Germ Cell Tumors: Tumors that arise from germ cells, commonly found in the ovaries or testes.
Dr. Purvi Kadakia Kutty, M.D. Pediatrics, FNB Pediatric Hematology & Oncology is a Consultant Pediatric Hematology & Oncology at Apollo Hospitals, Navi Mumbai.She is an Honorary-visiting consultant in the Division of Pediatric Hematology Oncology at L.T.M.G.H., Sion Hospital. She has experience of over 10 years in the field of Pediatric Hematology, Immunology & Oncology. She is also experienced in Pediatric Bone marrow transplantsfor benign and malignant hematological conditions.Kharghar, Navi Mumbai
Diagnostic Tests in Pediatric Oncology:
To diagnose Child Oncologist, pediatric oncologists may utilize a range of diagnostic tests, including:
Biopsy: A procedure to obtain a tissue sample for examination under a microscope to determine if cancer cells are present.
Imaging Studies: Techniques like X-rays, CT scans, MRI, and PET scans are used to visualize tumors and evaluate the extent of cancer.
Bone Marrow Aspiration and Biopsy: These tests help assess if cancer has spread to the bone marrow.
Lumbar Puncture (Spinal Tap): A procedure to collect cerebrospinal fluid for evaluation if cancer involves the central nervous system.
Dr. Purvi Kadakia Kutty's dedication to oncology and her unwavering commitment to her patients make her one of the best oncologists in Kharghar. Her extensive training, compassionate care, and holistic approach to treatment ensure that her patients receive the best possible care during their most challenging times. Dr. Kutty stands out as a beacon of hope and excellence in the field of oncology.
Visit: https://childoncologist.com/
Contact: +91 77381 62020
#ChildOncologist#ChildOncologistinKharghar#ChildOncologistinnavimumbai#Bestoncologistinnavimumbai#bestoncologistinKharghar
0 notes
Text
Spotlight on Paediatric Brain Tumours: Types, Treatments, and Survival Rates

Paediatric brain tumours, though relatively rare, represent one of the most devastating forms of cancer affecting children in India and worldwide. At Blood and Cancer Institute, our team of paediatric cancer specialists in Surat, understand the unique challenges and complexities involved in diagnosing and treating these tumours in young patients.
Brain tumours in children can arise from various types of cells within the brain or surrounding tissues. While some tumours may be non-cancerous (benign), others can be malignant (cancerous) and potentially life-threatening. Understanding the different types of paediatric brain tumours is crucial for determining the most effective course of treatment and improving survival rates.
Types of Paediatric Brain Tumours
1. Astrocytomas: These tumours originate from star-shaped cells called astrocytes, which play a supportive role in the brain. Astrocytomas can range from low-grade (slow-growing) to high-grade (aggressive) tumours.
2. Medulloblastomas: Commonly found in the cerebellum (the part of the brain responsible for balance and coordination), medulloblastomas are highly malignant tumours that can spread to other parts of the brain and spinal cord.
3. Ependymomas: These tumours develop from ependymal cells lining the ventricles (fluid-filled spaces) and the central canal of the spinal cord. Ependymomas can occur in various parts of the brain and spinal cord.
4. Gliomas: Gliomas are tumours that arise from glial cells, which provide support and protection for neurons in the brain. They can be further classified as low-grade or high-grade gliomas, depending on their aggressiveness.
5. Craniopharyngiomas: Cancer specialists in Surat say that these rare, non-cancerous tumours that develop from cells near the pituitary gland, which is responsible for producing important hormones that regulate growth and development.
Treatments for Paediatric Brain Tumours
At Blood and Cancer Institute, one of the best cancer hospitals in Surat, our multidisciplinary team of specialists collaborates closely to develop comprehensive treatment plans tailored to each child’s unique needs. The treatment approach may involve one or more of the following:
1)Chemotherapy: Various chemotherapy drugs may be used to shrink or control the growth of brain tumours, either alone or in combination with other treatments.
2. Radiation Therapy: Precision radiation techniques, such as intensity-modulated radiation therapy (IMRT) and proton therapy, can target the tumour with high doses of radiation while sparing nearby healthy tissues.
3. Targeted Therapy: Newer therapies target specific molecular pathways or genetic mutations involved in tumour growth, offering a more personalized approach to treatment.
4. Supportive Care: Our team of paediatric cancer specialists in Surat lays importance on providing comprehensive supportive care services, including physical therapy, occupational therapy, and psychological support, to help children and their families cope with the challenges of diagnosis and treatment.
Survival Rates and Long-Term Outlook
The prognosis for paediatric brain tumours varies depending on several factors, including the type and location of the tumour, the extent of surgical resection, the child’s age, and the overall health status. “Early detection and timely intervention play a crucial role in improving survival rates and long-term outcomes”, say the experts giving cancer treatment in Surat.
According to data from the Indian Council of Medical Research (ICMR), the overall 5-year survival rate for paediatric brain tumours in India is approximately 60–70%. However, survival rates can vary significantly based on the tumour type and other factors.
For example, the 5-year survival rate for low-grade astrocytomas is generally higher, ranging from 80–90%, while the rate for aggressive tumours like medulloblastomas and high-grade gliomas can be lower, ranging from 50–60%.
At BCI, one of the best cancer hospitals in Surat, we remain committed to providing cutting-edge treatments and personalized care to improve survival rates and quality of life for children with brain tumours. Our dedicated team of specialists works tirelessly to advance research, develop new therapies, and offer hope to families facing this challenging diagnosis.
Ongoing Support and Follow-Up Care
Even after successful treatment, children who have battled brain tumours often require ongoing support and follow-up care to address potential long-term side effects and complications, says our cancer specialist in Surat at BCI- Blood and Cancer Institute. These may include cognitive impairments, hormonal imbalances, vision or hearing problems, and secondary cancers.
Our hospital’s comprehensive follow-up program ensures that children receive regular monitoring, rehabilitation services, and psychosocial support to help them thrive and achieve their full potential. We also provide education and resources for families to empower them in navigating the journey of survivorship.
Conclusion
While paediatric brain tumours present significant challenges, advancements in medical science and the dedication of paediatric cancer specialist in Surat at hospitals like BCI offer hope for better outcomes. By raising awareness, supporting research efforts, and providing compassionate care, we can make a difference in the lives of children affected by these complex and often devastating conditions.
0 notes
Text
0 notes